Naftifine dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Naftifine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARM...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Dosage and Administration== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARMACEUTICALS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af | publisher = | date = | accessdate = }}</ref> | A sufficient quantity of Naftin® Cream, 1% should be gently massaged into the affected and surrounding skin areas once a day. A sufficient quantity of Naftin® Gel, 1% should be gently massaged into the affected and surrounding skin areas twice a day, in the morning and evening. The hands should be washed after application. If no clinical improvement is seen after four weeks of treatment with Naftin® Cream or Gel, 1%, the patient should be re-evaluated.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NAFTIN (NAFTIFINE HYDROCHLORIDE) CREAM [MERZ PHARMACEUTICALS, LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 03:47, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Dosage and Administration
A sufficient quantity of Naftin® Cream, 1% should be gently massaged into the affected and surrounding skin areas once a day. A sufficient quantity of Naftin® Gel, 1% should be gently massaged into the affected and surrounding skin areas twice a day, in the morning and evening. The hands should be washed after application. If no clinical improvement is seen after four weeks of treatment with Naftin® Cream or Gel, 1%, the patient should be re-evaluated.[1]
References
Adapted from the FDA Package Insert.